TARS Tarsus Pharmaceuticals, Inc.

NASDAQ
$72.70

Tarsus Pharmaceuticals, Inc. (TARS) Institutional Ownership

What the institutions did with TARS last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
285
filed a 13F this quarter
Managers holding
252
+3 on the quarter
Buyers
140
36 opened new
Sellers
116
33 sold out entirely
Buyer share
54.7%
of managers who traded it
Breadth
+9.4
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
BlackRock, Inc. 3.9M 8.0%
Deep Track Capital, LP 3.7M 7.6%
RTW INVESTMENTS, LP 3.4M 7.0%
Jupiter Topco LLC 2.8M 5.8%
Paradigm Biocapital Advisors LP 2.8M 5.8%
Assenagon Asset Management S.A. 1.9M 3.9%
MORGAN STANLEY 1.8M 3.8%
VANGUARD CAPITAL MANAGEMENT LLC 1.8M 3.7%
JENNISON ASSOCIATES LLC 1.7M 3.4%
TANG CAPITAL MANAGEMENT LLC 1.6M 3.3%
MILLENNIUM MANAGEMENT LLC 1.4M 3.0%
BANK OF AMERICA CORP /DE/ 1.2M 2.5%
GEODE CAPITAL MANAGEMENT, LLC 1.1M 2.3%
STATE STREET CORP 1.1M 2.2%
Vestal Point Capital, LP 1.1M 2.2%
Invesco Ltd. 785.8K 1.6%
GOLDMAN SACHS GROUP INC 742.7K 1.5%
Frazier Life Sciences Management, L.P. 728.6K 1.5%
D. E. Shaw & Co., Inc. 710.6K 1.5%
FMR LLC 672.9K 1.4%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 607.3K 1.3%
Clearbridge Investments, LLC 549.4K 1.1%
TORONTO DOMINION BANK 510.3K 1.1%
LORD, ABBETT & CO. LLC 479.3K 1.0%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 427.0K 0.9%

Largest changes

Manager Action Previous Current Change
MILLENNIUM MANAGEMENT LLC Increased 564.6K 1.4M +862.5K
Vestal Point Capital, LP Increased 200.0K 1.1M +850.0K
Assenagon Asset Management S.A. Increased 1.3M 1.9M +614.8K
Driehaus Capital Management LLC Reduced 926.1K 317.6K -608.5K
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ New 0 427.0K +427.0K
TANG CAPITAL MANAGEMENT LLC Increased 1.2M 1.6M +379.6K
WASATCH ADVISORS LP New 0 368.6K +368.6K
LORD, ABBETT & CO. LLC Reduced 842.3K 479.3K -363.0K
BlackRock, Inc. Increased 3.6M 3.9M +303.5K
GOLDMAN SACHS GROUP INC Increased 439.6K 742.7K +303.1K
BRAIDWELL LP Sold Out 265.7K 0 -265.7K
Point72 Asset Management, L.P. Sold Out 226.3K 0 -226.3K
Nuveen, LLC Reduced 315.3K 96.8K -218.5K
Paradigm Biocapital Advisors LP Increased 2.6M 2.8M +213.5K
Qube Research & Technologies Ltd Reduced 324.0K 116.4K -207.7K
Integral Health Asset Management, LLC Sold Out 200.0K 0 -200.0K
MACKENZIE FINANCIAL CORP New 0 191.4K +191.4K
M&G PLC Sold Out 166.4K 0 -166.4K
Parkman Healthcare Partners LLC New 0 150.0K +150.0K
Cormorant Asset Management, LP Reduced 225.0K 100.0K -125.0K
MORGAN STANLEY Reduced 1.9M 1.8M -117.2K
JPMORGAN CHASE & CO Increased 30.5K 140.0K +109.5K
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Increased 499.9K 607.3K +107.4K
BNP PARIBAS FINANCIAL MARKETS Reduced 303.5K 201.6K -101.9K
Schonfeld Strategic Advisors LLC New 0 99.8K +99.8K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.